medisourceasia.com

Industry News


About 
medisourceasia

Magazine
Industry News
Global Trends
Events Calendar
Web Links

Web Gallery

Advertising  Info

Contact

 

IPR Comes With New Hi-tech Medical Waste Disposable Plan For Hospitals

Hospitals may soon be able to dispose off medical wastes in an eco-friendly manner using a new technology. Gandhinagar based Institute of Plasma Research (IPR) has developed a new non-burn technology - plasma pyrolysis process - which will make it possible to dispose off medical wastes without using traditional methods of burning or dumping the same.

"We have sent the relevant data obtained from the use of technology to the central pollution control board (CPCB) for their approval. Once we get the approval, we will be able to sell the equipment on our own," says Dr PN Bhagwati, MD, Bhagwati Pyrotech Ltd. The company has secured the waste disposable technology from IPR for commercialization.

The new process may be helpful to dispose off an estimated 1.75 lakh kg of bio-toxic wastes across seven lakh hospitals in the country every day. The process uses graphite based plasma torch to destroy the wastes, unlike use of incinerators which produces hazardous gases.

What's more, the energy generated in the disposable process can be used to generate electricity. "The energy generated in the process will be able to generate more power, says P I John, a professor at IPR.

The institute claims that plants for disposable, each of which costs around Rs. 25 lakh, are being used at four different places, including Goa Medical College (Goa), Andaman & Nicobar Islands, Dharamshala in Himachal Pradesh, and Gangtok in Sikkim.

The government of India's department of science and technology will have another 20 such plants at various places across the country.

"The next plants will come up in Andhra Pradesh, UP, Haryana and Tripura," says Neerav Jamnapara, the in-charge of technology commercialization and transfer cell, IPR.

The current plant has a capacity to destroy 75 kg of waste per day. IPR now wants to use the same technology to destroy 40 kg of wastes per hour. Besides, it is also in the process of designing plants for the treatment of agro, chemical and industrial wastes.

However, experts say that the idea of producing electricity seems difficult to implement. "The plasma technology is in use for quite sometime now in several countries. The idea of producing energy requires a standard amount of bio-medical wastes. The technology should also be affordable," said Jagruti Bhatia, business head, consulting division of Hosmac India Pvt. Ltd.

(Ref : The Economic Times dated February 12, 2007)

Fresenius To Expand Dialyzer Production Capacity At St Wandel

Fresenius Medical Care is expanding the dialyzer production capacity at the St. Wandel (Germany) production facility by 40 percent. A total of 36 million will be invested including associated investment in additional production capacity for proprietary Helixone Fibers.

The new production line for FX-Class dialyzers is expected to start operating in spring 2008 and will increase the annual capacity from 25 million to 35 million a Fresenius press release stated.

The expansion plan at Fresenius Medical Care's major European dialyzer production facility in St. Wandel (Germany) follows recent significant expansion projects at the Company's facilities in Ogden (Utah, US) and Buzen (Japan). As a result of these two expansion projects, the total annual capacity is expected to increase by about 11 million dialyzers worldwide.
Dr. Ben Lipps, chief executive officer of Fresenius Medical Care, commented: "The continued expansion of our global production network is in response to the strong increase in global demand for Fresenius Medical Care's single use dialyzers and other innovative products to treat patient with chronic kidney disease. Furthermore, the investment at the St. Wendel plant demonstrates our strong commitment to our home country Germany and to our more than 1,500 employees, who have built up tremendous proprietary expertise for cost effective production of high quality, innovative and successful dialysis products."

In haemodialysis, the dialyzers acts as an artificial kidney, providing the vital functions of the natural organ : Blood flows through as many as 20,000 nearly harifine tubes (capillaries) in a plastic housing. The Helixone capillaries are made from Polysulfone, a special polymer with very good filtering capabilities and excellent biocompatibility. Toxins as well as excess water are filtered from the blood through pores in the capillaries and removed with dialysis fluid (dialysate).

(Ref : Chronicle Pharmabiz dated January 25, 2007)


Next

Other News

Centralised Licensing With Inadequate Staff May Lead To Delay In Granting Product Licences
Central Drug Authority Will Be Formed In Six Months : Dr Ramadoss
Fresenius Medical Picks Up Majority Stake In Taiwanese Dialysis Firm
The Corporate Healthcare Segment May Replicate The Success Of The Indian IT Sector, Say Experts
Marck Biosciences In Talks With US Cos For Site Transfer
Ranbaxy Group Forays Into Retail Healthcare
Corona Cardiac Cathlab

Archives

Advertisement

 

 


Back | Back To Top | Previous | Next